QA: Cellectar Biosciences Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2022_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc

  xvar xval
0 AssetsCurrent 36,571,460
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 344,491
3 remainder_Assets 285,858
4 LiabilitiesCurrent 3,990,363
5 LiabilitiesNoncurrent 166,292
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,076,614
9 ResearchAndDevelopmentExpense 15,004,993
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,879
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 37,201,809
1 Liabilities 4,156,655
2 Expenses 21,081,607
3 Revenues 0
4 StockholdersEquity 33,045,154
5 NetIncome -21,079,728
6 ComprehensiveNetIncome -21,079,728
7 BaseVar 31,220,975
8 EconomicCapitalRatiobeforeLimitedLiability 2.46
9 EconomicCapitalRatio 3.33

Edgar->Model Mapping

Feature Distribution

Change over Time